# PARSABIV

NDC: 55513-740
Generic name: etelcalcetide
Labeler / Manufacturer: Amgen, Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20170403

FDA application: NDA208325

## Active ingredients

- ETELCALCETIDE HYDROCHLORIDE: 2.5 mg/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55513-740"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55513-740
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cd270093-c6a8-4596-a4ab-e6aa0a2c8a0c